EUVIMEDEUVIMED entdecken
Crossref

The evolution and advances of biomarker use in clinical trials for breast cancer treatment—a narrative review

Jing He, Yijun Jia

Translational Breast Cancer Research · 2021-01 · 2 · 6-6

DOI: 10.21037/tbcr-20-66 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Translational Breast Cancer Research, 2021-01. Verfasst von Jing He und 1 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

He, J., & Jia, Y. (2021). The evolution and advances of biomarker use in clinical trials for breast cancer treatment—a narrative review. Translational Breast Cancer Research, 2, 6-6. https://doi.org/10.21037/tbcr-20-66

Vancouver

He J, Jia Y. The evolution and advances of biomarker use in clinical trials for breast cancer treatment—a narrative review. Translational Breast Cancer Research. 2021;2:6-6. doi:10.21037/tbcr-20-66

BibTeX
@article{He2021,
  author = {He, Jing and Jia, Yijun},
  title = {The evolution and advances of biomarker use in clinical trials for breast cancer treatment—a narrative review},
  journal = {Translational Breast Cancer Research},
  year = {2021},
  volume = {2},
  pages = {6--6},
  doi = {10.21037/tbcr-20-66}
}
Kostenlos starten →